Urology

Recent research comparing laparoscopic and open radical prostatectomy outcomes shows that radical prostatectomy leads to shorter hospital stays.

The primary treatment for intermediate and high-risk NMIBC includes transurethral resection of the bladder tumour.

New research shows that at-home prostate cancer tests are producing inconsistent and inaccurate results.

A study of 666 localised prostate tumours identified 223 driver regions, many influenced by structural variations undetectable via targeted sequencing.

Lower oestradiol and FSH levels are linked to renal cell carcinoma, highlighting potential hormonal influences on tumour progression.

The results suggest trends towards overall survival and progression-free survival improvements with pembrolizumab in combination with platinum-based chemotherapy.

Danish study finds anticholinergic bladder drugs linked to dementia risk, but not when compared to mirabegron.

The combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible and safe treatment strategy.